| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 8.30 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
UAE Neurology Devices Market Analysis
The UAE Neurology Devices Market is expected to register a CAGR of 8.3% during the forecast period.
The market studied is witnessing rapid growth, driven by a confluence of factors such as the rising incidence of neurological disorders, substantial investments in neurology devices by private enterprises, and a burgeoning elderly population.
The rise in neurological disorders, including brain aneurysms, brain tumors, and epilepsy, is a key driver of market growth. For instance, according to an article published by the Multidisciplinary Digital Publishing Institute (MDPI) in June 2022, a study conducted in the United Arab Emirates stated that a brain aneurysm is a critical condition that mostly affects young adults and may cause life-threatening complications such as brain hemorrhage. Thus, the significant burden of neurological diseases is expected to contribute to the growth of the market over the forecast period.
Furthermore, patients with untreated unruptured aneurysms have 50% excess long-term mortality compared with the general population, and one of the most innovative treatment options for brain aneurysms is the use of a flow-diverting stent (FDS). Thus, the high burden of diseases such as brain aneurysms and the increasing use of neurology devices such as FDS are expected to boost market growth. Moreover, according to an article published by PubMed Central in November 2022, brain and central nervous system cancer was among the most common forms of cancer in the United Arab Emirates. Thus, the high prevalence of such neurological disorders is expected to enhance the usage of neurological devices in the country and, therefore, propel market growth.
Moreover, strategic activities by market players, such as product launches and mergers and acquisitions, are expected to contribute to the market’s growth over the forecast period. For instance, in September 2022, Brain Navi strategically partnered with Medtreq Medical Equipment, a prominent distributor, to enhance the distribution network of its surgical navigation robot, NaoTrac, across the GCC region, with a specific focus on the United Arab Emirates. Such activities are likely to increase access to these devices and, therefore, boost market growth.
Thus, the increasing prevalence of neurological disorders, coupled with heightened research and development activities, is anticipated to drive market growth during the forecast period. However, the high cost of equipment is likely to impede this growth.
UAE Neurology Devices Market Trends
Neurostimulation Devices Segment is Expected to Witness Significant Growth Over the Forecast Period
Neurostimulation devices are considered implantable and programmable medical devices that deliver electrical stimulation effectively to specific parts of the patient's brain, spinal cord, or peripheral nervous system to help treat various conditions, including chronic pain and movement disorders. Hence, with increasing incidences of various diseases such as overactive bladder and urinary incontinence, the neurostimulation devices segment is expected to grow during the forecast period.
According to an article published by PubMed Central in December 2022, a study conducted in the United Arab Emirates showed that the quality of life was affected in an estimated 90% of the patients suffering from urinary incontinence. Thus, the increasing burden of urinary incontinence is expected to boost the usage of nerve stimulation, as nerve stimulation is widely used in the treatment of urinary incontinence.
Furthermore, according to an article published by Cureus in May 2022, a study was conducted in the country that examined the prevalence of urinary incontinence in women. It was found that the prevalence of urinary incontinence was 42.2% among women. Moreover, the rising adult and geriatric population in the country is also expected to boost segment growth, as these diseases are mainly associated with these age groups.
Hence, the aforementioned factors, such as the rising prevalence of fecal incontinence and urinary incontinence and the rising adult and geriatric population, are expected to boost the segment’s growth during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
Neurosurgery Devices Segment is Expected to Witness Significant Growth During the Forecast Period
Neurosurgery devices are devices that are used for the surgical treatment of various brain and spinal cord diseases. These devices are mainly used for the treatment of various neurological diseases such as dystonia, Alzheimer's disease, Parkinson's disease, and epilepsy, among others. The rising prevalence of such neurological disorders in the country and the rising geriatric population are expected to boost segment growth.
According to an article published by the Multidisciplinary Digital Publishing Institute (MDPI) in August 2022, a study was conducted in the country, which showed that the prevalence rate of Parkinson's disease is high in the country. Early diagnosis and prompt treatment initiation are important, as they have a huge socio-economic impact in the country. Thus, the high prevalence of Parkinson's disease in the country is expected to boost segment growth.
Furthermore, according to a new study released by the Lancet Public Health in January 2022, the United Arab Emirates and other Gulf countries were predicted to report the highest increases in the number of people living with dementia over the next 30 years worldwide. It was estimated that the United Arab Emirates will witness an increase of 1,795% in people suffering from dementia by 2050. Thus, the high number of dementia cases is expected to increase the prevalence of Alzheimer's disease in the region over the forecast period, thereby propelling market growth.
Therefore, the aforementioned factors, such as the rising prevalence of Alzheimer's and Parkinson's diseases and the rising geriatric population, are expected to boost the segment’s growth during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
UAE Neurology Devices Industry Overview
The UAE neurology devices market is semi-consolidated. There are market participants involved in R&D for the development of advanced simulation and neuromodulation techniques with minimally invasive procedures that are preferable to the patients. Furthermore, many private companies are showing great interest in developing novel neurological devices to earn huge profits. In the coming years, few other players are expected to enter the market. Some of the major players in the market are Stryker Corporation, Medtronic PLC, Abbott Laboratories, Johnson and Johnson, and Smith & Nephew.
UAE Neurology Devices Market Leaders
-
Stryker Corporation
-
Medtronic PLC
-
Abbott Laboratories
-
Nihon Kohden Corporation
-
Johnson and Johnson
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
UAE Neurology Devices Market News
- June 2023: The Neuroscience Institute located at Burjeel Medical City (BMC) collaborated with Northwell Health to provide state-of-the-art care for adult and pediatric patients with neurological disorders.
- June 2022: A phase 1/2 clinical trial was started by Abu Dhabi Stem Cells Center (ADSCC), which evaluated the safety and effectiveness of a cutting-edge immunotherapy called extracorporeal photopheresis in people with multiple sclerosis (MS).
UAE Neurology Devices Industry Segmentation
Neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury.
The UAE neurology devices market is segmented by type of device: cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device, and other types of devices.
The report offers the value (USD) for the above segments.
| By Type of Device | Cerebrospinal Fluid Management Devices |
| Interventional Neurology Devices | |
| Neurosurgery Devices | |
| Neurostimulation Devices | |
| Other Types of Devices |
Need A Different Region or Segment?
Customize Now
UAE Neurology Devices Market Research FAQs
What is the current UAE Neurology Devices Market size?
The UAE Neurology Devices Market is projected to register a CAGR of 8.30% during the forecast period (2025-2030)
Who are the key players in UAE Neurology Devices Market?
Stryker Corporation, Medtronic PLC, Abbott Laboratories, Nihon Kohden Corporation and Johnson and Johnson are the major companies operating in the UAE Neurology Devices Market.
What years does this UAE Neurology Devices Market cover?
The report covers the UAE Neurology Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the UAE Neurology Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
UAE Neurology Devices Industry Report
Statistics for the 2025 UAE Neurology Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. UAE Neurology Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
